← Leaderboards
Jay R. Lieberman
University Of California Los Angeles
$6,899,796
Attributed
$6,899,796
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $604.8K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$6,899,796 · 3
By mechanism
R01$6,899,796 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Lily Wu$3,586,954
- Isidro B. Benjamin Salusky$22,568,917
- Loren Gi Fong$14,142,294
- Cun-Yu Wang$42,747,305
- Min Lee$5,666,497
Others in their field
Top investigators on “Bone Morphogenetic Proteins”
- Marlene Rabinovitch · Stanford University$21,709,813
- John A Kessler · Northwestern University$15,344,538
- Kristina I Bostrom · University Of California Los Angeles$15,121,244
- Akiko Hata · University Of California, San Francisco$14,378,243
- Martin M Matzuk · University Of Missouri-Columbia$13,743,367
- Mary C Mullins · University Of Pennsylvania$10,606,462
Research focus
Bone Morphogenetic ProteinsBone MarrowGene TherapyOsteogenesisBiologicalCellsHarvestHealingImplantationComplementary DnaBone Marrow CellsDefectClinical DataImmune ResponseBiodistributionBone QualityBone RegenerationCellular TransductionFractureComparative EfficacyBone CellBoneBone LossImplant
Grant awards (20)
Regional Gene Therapy to Enhance Bone Repair$402,803
R01 · FY2021 · AR · contact PI
Regional Gene Therapy to Enhance Bone Repair$442,041
R01 · FY2020 · AR · contact PI
Regional Gene Therapy to Enhance Bone Repair$425,801
R01 · FY2019 · AR · contact PI
Regional Gene Therapy to Enhance Bone Repair$59,405
R01 · FY2019 · AR · contact PI
Regional Gene Therapy to Enhance Bone Repair$425,868
R01 · FY2018 · AR · contact PI
Regional Gene Therapy to Enhance Bone Repair$604,757
R01 · FY2017 · AR · contact PI
The Use of Regional Gene Delivery to Heal Critical Sized Bone Defects$313,154
R01 · FY2014 · AR · contact PI
The Use of Regional Gene Delivery to Heal Critical Sized Bone Defects$302,875
R01 · FY2013 · AR · contact PI
The Use of Regional Gene Delivery to Heal Critical Sized Bone Defects$299,376
R01 · FY2012 · AR · contact PI
The Use of Regional Gene Delivery to Heal Critical Sized Bone Defects$298,890
R01 · FY2011 · AR · contact PI
The Use of Regional Gene Delivery to Heal Critical Sized Bone Defects$309,825
R01 · FY2010 · AR · contact PI
RANKL and BMPs in Prostate Cancer Induced Bone Lesions$312,236
R01 · FY2007 · CA · contact PI
RANKL and BMPs in Prostate Cancer Induced Bone Lesions$335,684
R01 · FY2006 · CA · contact PI
RANKL and BMPs in Prostate Cancer Induced Bone Lesions$343,763
R01 · FY2005 · CA
RANKL and BMPs in Prostate Cancer Induced Bone Lesions$341,908
R01 · FY2004 · CA
Regional Gene Therapy to Enhance Bone Repair$325,969
R01 · FY2004 · AR
RANKL and BMPs in Prostate Cancer Induced Bone Lesions$339,683
R01 · FY2003 · CA
Regional Gene Therapy to Enhance Bone Repair$325,969
R01 · FY2003 · AR
Regional Gene Therapy to Enhance Bone Repair$326,414
R01 · FY2002 · AR
Regional Gene Therapy to Enhance Bone Repair$363,375
R01 · FY2001 · AR